Biological Markers & Diagnosis of Unstable Plaques
|
|
- Brittney Hawkins
- 5 years ago
- Views:
Transcription
1 Identification of vulnerable atherosclerotic plaques and impact on treatment decision Chairmen : A. K. Banerjee, C. Erol Stocholm, August 30 th, 2010 Biological Markers & Diagnosis of Unstable Plaques C.D. Liapis MD, FACS, FRCS, Professor and Chairman Department of Vascular Surgery Attikon University Hospital Athens University Medical School
2 Atherosclerosis αθήρι (athere=gruel) and σκληρός (skleros=hard) Atherosclerosis develops over the course of the years, beginning in the early teens. Progressive lumen stenosis of cardiac or extracardiac arteries triggers ischemia However abrupt plaque rupture or erosion and consequent thrombosis leads to acute cardiovascular events C.Liapis. Atherosclerotic Risk Factors. Ruterfords 7 th Edition 2010
3 Vulnerable plaque The Challenge of Terminology Vulnerable : susceptible to injury or susceptible to attack, as in we are vulnerable both by water and land, without either fleet or army (Alexander Hamilton). Vulnerable Plaque: thrombosis-prone plaques with a high probability of undergoing rapid progression, thus becoming culprit plaques Vulnerable Plaque: A Prospective Term Culprit Plaque: A Retrospective Term Vulnerable Plaque = Future Culprit Plaque
4 The Vulnerable Patient Consensus Statement Lessons Learned by Coronary Plaques Naghavi et al. Circulation. 2003;108:1664
5 Vulnerable plaque Vulnerable plaque: Thin fibrous cap, large necrotic lipid core, inflammation, less calcium deposition, surface irregularities Vulnerable plaque prone to rupture, erosion and/or thrombosis leads to: 1. Acute coronary syndromes 2. Ischemic strokes and transient ischemic attacks (TIAs)
6 Markers for Defining Vulnerable Plaque Major criteria Active inflammation (monocyte/macrophage -T-cells) Thin cap with large lipid core Endothelial denudation & platelet aggregation Fissured plaque Critical Stenosis Minor criteria Superficial calcified nodule Glistening yellow Intraplaque hemorrhage Endothelial dysfunction Outward (positive) remodeling
7 Carotid vs Coronary Vulnerable Plaque Carotid Artery Disease STROKE ~ Coronary Artery Disease AMI y) Virmani R et al. Neurosurgery 2006
8 Why is it important to detect the Vulnerable Plaque? RISK OF STROKE,MI,CARDIO VASCULAR DEATH Patient Selection & Treatment Planning
9 Markers of Vulnerability Imaging Biological Markers
10 Current diagnostic modalities are insufficient to detect vulnerable carotid lesions DSA CTA MRA Adequate for anatomy and degree of stenosis but... No accurate info on plaque activity and composition
11 Imaging of The Vulnerable Plaque Ultrasound Plaque Classification based on ultrasonic appearance Type I (uniformly echolucent) Type II (predominately echolucent) Type III (predominately echogenic) Type IV (uniformly echogenic) Type V (heavy calcification) Lack of uniformity on reporting, operator dependency and the settings used on the equipment limited its widespread use for clinical management of patients.
12 Imaging of The Vulnerable Plaque Ultrasound Gray Scale Median (Computer analyzed global echogenicity of the plaque) Low GSM (<25), echolucent/high risk plaques High GSM (>25), echogenic/low risk plaques
13 Imaging of The Vulnerable Plaque Ultrasound Gray Scale Median... - is a predictor of stroke in natural history studies - is a predictor of stroke during CAS - does not modify the risk of stroke during CEA Biasi, G. M. et al. Circulation 2004
14 Ultrasonographic Risk Score of Carotid Plaques
15 Imaging of The Vulnerable Plaque Intravascular ultrasound (IVUS) Provides real-time, cross-sectional and high-resolution images with 3-D reconstruction capabilities - Advantages - Shows morphology of plaque - Differs between stable and unstable plaques - Disadvantages - Doesn t give information about inflammation - Low spatial resolution ( ~ 200 µm ) - Deeper plaque is not imaged
16 Imaging of The Vulnerable Plaque IVUS Virtual Histology Compared with histology, IVUS-VH correctly identified the presence of fibrous, fibro-fatty, and necrotic tissue in 58.33%, 38.33%, and 38.33% of lesions, respectively. IVUS-VH was not accurate in detecting the relative amount of specific plaque components Granada JF, et al, Arterioscler Thromb Vasc Biol 2007
17 Imaging of The Vulnerable Plaque Optical Coherence Tomography Measures the intensity of reflected near-infrared light from tissue - Advantages - Very high resolution ( ~ 10 µm ) - Near video rate ( 8 frames/sec. ) - Catheters are small ( inch ) - Disadvantages - Long image acquisition time - Cost - Limited penetration - Lack of physiologic data
18 Imaging of The Vulnerable Plaque High resolution MRI
19 Imaging of The Vulnerable Plaque Molecular MRI
20 Imaging of The Vulnerable Plaque High resolution MRI & PET High-resolution MRI and 18F-FDG PET in a patient with recent stroke, demonstrating increased metabolic activity in a plaque causing severe stenosis of the left internal carotid artery Muir KW. Inflammation and ischemic stroke. Curr Opin Neur 2007
21 Imaging of The Vulnerable Plaque High resolution PET & PET/CT Tahara, N. et al. J Am Coll Cardiol 2006;48 Tahara, N. et al. J Am Coll Cardiol 2007;49:1533
22 Imaging of The Vulnerable Plaque Emerging imaging technology Predicts the Vulnerable Plaque Adequate for plaque activity and composition but High operator dependence Poor diagnostic accuracy Invasive EXPENSIVE
23 Biomarkers, if applicable: Non operator dependent Non invasive Cost effective High sensitivity specificity (?)
24 Evolving Biomarkers in Carotid Vulnerability: Inflammatory markers CRP Fibrinogen Cytokines (TNF-a, IFN-g, IL-1b, IL-6, IL-8, IL-4, IL-10) MMPs (MMP-7, MMP-8, MMP-9, MMP-12) Infectious markers Chlamydia pneumoniae Helicobacter Cytomegalovirus Haemostatic markers Fibrinogen D-dimers Plasminogen activator inhibitor (PAI) Procoagulant factor VII Vascular calcification markers Osteopontin Osteoprotegerin Genomics & Proteomics (New Biomarker Targets)
25 Current Evidence for Biomarkers as predictors of vulnerable carotid plaques They predict the natural history of carotid and cerebrovascular disease They predict perioperative risk They may guide medical treatment They may guide carotid intervention (technique, timing etc)
26 Biomarkers as early predictors of cerebrovascular events 26 Follow up studies stratified by biomarker category and number of patients recruited. 19 demonstrate a positive prediction
27 Biomarkers as early predictors of cerebrovascular events 26 Follow up studies stratified by biomarker category and number of patients recruited. 19 demonstrate a positive prediction
28 Biomarkers as diagnostic tools of cerebrovascular events 20 Studies comparing symptomatic (stroke) and asymptomatic patients. 16 demonstrate a positive correlation
29 Biomarkers as diagnostic tools of cerebrovascular events 20 Studies comparing symptomatic (stroke) and asymptomatic patients. 16 demonstrate a positive correlation
30 Biomarkers predict the natural history of carotid and cerebrovascular disease Prospective studies relating baseline plasma CRP levels to the risk of first cerebrovascular event Di Napoli, M. et al. Stroke 2005
31 Biomarkers predict the natural history of carotid and cerebrovascular disease HRs of Ischemic stroke associated to baseline concentrations of CRP and Fibrinogen Patients with high levels of both CRP & Fibrinogen exhibit additive risk Tanne D. et al. Stroke 2006;37:
32 Biomarkers predict the natural history of carotid and cerebrovascular disease Patients indicated for CEA depict significantly higher blood cytokine levels Profumo et al. Clin Exp Immunol 2008
33 Biomarkers predict the natural history of carotid and cerebrovascular disease Elevated levels of MMP-9 in patients with >50% carotid stenosis are associated with a 2-fold risk of ipsilateral stroke or cardiovascular death. Eldrup N et al. Circulation 2006
34 Biomarkers predict the natural history of carotid and cerebrovascular disease Patients with CAD (76 asymptomatic & 69 symptomatic) MMP-7, -8, -9 and TIMP-1 are significantly enhanced in symptomatic patients. Combination of more than one biomarker enhances significantly the positive predictive value (PPV) for neurological symptoms compared to single MMP Single MMP: PPV 62.5% MMP-7MMP-9: PPV 73.1% MMP-7MMP-8MMP-9: PPV 73.8% Heider P, Pelisek J, Poppert H, Eckstein HH. Vasc Endovasc Surg 2009
35 Biomarkers predict the natural history of carotid and cerebrovascular disease Anti Cp IgA seropositivity in symptomatic and asymptomatic patients 78 patients indicated for CEA. Serum levels of Cp IgA are significantly correlated with CAD symptomatology asympt pts 30 p=< anti-cp IgA (-) 0 asymptom atic pts sym ptomati c pts () Kaperonis EA, Liapis CD, et al, JVS 2006
36 Biomarkers predict the natural history of carotid and cerebrovascular disease The Caerphilly study followed for 4 years suggests that fibrinogen, d-dimer, plasminogen activator inhibitor (PAI) activity, and procoagulant factor VII are independent risk factors that increase the prediction of stroke in middle aged men. Smith A et al. Circulation 2005
37 Biomarkers predict the natural history of carotid and cerebrovascular disease Vascular calcification markers predict carotid symptomatology 114 patients with CAD >50% ICA stenosis VARIABLES\ GROUPS Osteopontin (ng/ml) Osteoprotegerin (pmol/l) Symptomatic (60 pts) Asymptomatic (54 pts) Controls (50 pts) 79.72±51.1 a,b 54.58±27.91 c 41.84± P values p< ±4.02 a,b 6.78±2.05 c 5.74±2.39 p<0.05 hscrp (mg/l) 4.49±2.09 a,b 2.93±1.95 c 1.68±0.93 p<0.05 GSM 57.41±38.19 a 76.32±36.72 (a) p<0.05 group A vs B, (b) p<0.01 group A vs C, (c) p<0.05 group B vs C Kadoglou N, Liapis C, et al. J Vasc Surg 2008
38 Athero-Express Biobank Study - The study has succeeded to identify plaque characteristics that are predictive of restenosis and cardiovascular events after CEA - Combination of the prospective study design with a proteomics approach has enabled identification of several potential biomarkers to predict risk of future cardiovascular events - The validation process of these markers is ongoing and is expected to yield additional predictive markers in the near future Project Leaders: Prof G Pasterkamp, Prof F. Moll
39 Biomarkers related to carotid intervention outcome n Intervention Prognostic Value Comment CRP or hscrp Heider P, et al CEA Independent hscrp (but not CRP) RF for new periprocedural DWI cerebral lesions Groschel K, et al CAS Independent CRP RF of post-cas 30d stroke and death Fibrinogen Heider P, et al CEA Independent RF for new periprocedural DWI cerebral lesions WBC Aronow HD, et al CAS Independent Increased preprocedural WBC count is a RF for microembolic signals in TCD IL-6 Abe Y, et al CAS Independent Higher IL-6 levels were associated with new ischemic lesions All studies showed a positive prediction but the numbers of patients were small..
40 Biomarkers predict perioperative risk Preoperative levels of hscrp & Fibrinogen predict microembolization during CEA 183 patients with high grade ICA stenosis. The higher preop hscrp or Fibrinogen predicted higher rates of new cerebral lesions in postoperative diffusion weighted imaging Heider P, Eckstein HH, et al. JVS 2007;46
41 Biomarkers predict perioperative risk Preoperative levels of WBC predict microembolization during CAS Greater pre-procedure WBC is associated with more frequent TCD-detected distal embolisation during CAS. Aronow HD, et al Stroke 2005
42 Biomarkers predict perioperative risk Elevated CRP predicts perioperative stroke and death following CAS Groeschel K, et al. AJNR 2007
43 Biomarkers and Vulnerable Plaque Predict the natural history of carotid disease Predict perioperative risk of embolization Biomarkers are a useful adjunct to detect the vulnerable carotid plaque
44 Guidelines Recommendation 6. Treatment options according to carotid plaque morphology Plaque morphology should be assessed in all cases before invasive treatment. The plaque at risk of peri-procedural embolisation should be identified by validated imaging (GSM, etc.) or other diagnostic techniques such as biological markers [C]. Liapis CD, Bell PR, Mikhailidis D, Sivenius J, Nicolaides A, Fernandes e Fernandes J, Biasi G, Norgren L; ESVS Guidelines Collaborators. ESVS guidelines. Eur J Vasc Endovasc Surg. April 2009
45 Vulnerable Carotid Plaque and Treatment Planning RISK OF STROKE
46 ICSS Results 1,713 patients All Symptomatics (120 days) Lancet Feb 2010 The incidence of stroke, death, or procedural MI was 8,5% in the CAS group compared with 5,2% in the CEA group. Completion of long-term follow-up is needed to establish the efficacy of CAS compared with CEA.
47 % CREST Results N Engl J Med 2010 CREST ,1 C E 2 2,3 2,3 1 0 STROKE MI 1, patients 47% Asymptomatics On the composite primary endpoint of any stroke, myocardial infarction (MI) or death during the periprocedural period or ipsilateral stroke on follow-up, no significant difference
48 The Key for Carotid Intervention CAS Vulnerable Plaque??? CEA
49 Vulnerable Plaque oriented Stent and EPD Selection Vulnerable Plaques have a greater tendency to embolize Embolic protection devices prevent stroke during the procedure, whereas stents provide postprocedural stroke prevention.
50 Vulnerable Plaque oriented Stent and EPD Selection Proximal occlusion EPD (MOMA-INVATEC, PARODI -GORE) Embologenic lesions should preferably be managed with proximal EPD
51 Vulnerable Plaque oriented Stent and EPD Selection The broader the stent free cell area the higher the embolic event rate Bosiers et al. EJVES 2007
52 Biomarkers may also guide medical treatment Aggressive lipid lowering is more effective than moderate lipid lowering, in carotid plaque stabilization 1-year follow up study of 140pts with CAD not indicated for intervention Target LDL-C<100mg/dl Target LDL-C<70mg/dl Target LDL-C<100mg/dl Target LDL-C<70mg/dl Target LDL-C<100mg/dl Target LDL-C<70mg/dl Target LDL-C<100mg/dl Target LDL-C<70mg/dl Kadoglou N., Liapis C., et al. J Vasc Surg 2010
53 Conclusions Emerging imaging modalities & Biological markers Identify the vulnerable carotid plaque Choose the best interventional strategy NEED FOR INCLUSION IN RANDOMIZED STUDIES
54 Christos Liapis, MD, FACS, FRCS Professor of Vascular Surgery Director Department of Vascular Surgery National Kapodistrian University of Athens
55 You are cordially invited to attend..
Imaging Atheroma The quest for the Vulnerable Plaque
Imaging Atheroma The quest for the Vulnerable Plaque P.J. de Feijter 1. Department of Cardiology 2. Department of Radiology Coronary Heart Disease Remains the Leading Cause of Death in the U.S, Causing
More informationCT Imaging of Atherosclerotic Plaque. William Stanford MD Professor-Emeritus Radiology University of Iowa College of Medicine Iowa City, IA
CT Imaging of Atherosclerotic Plaque William Stanford MD Professor-Emeritus Radiology University of Iowa College of Medicine Iowa City, IA PREVALENCE OF CARDIOVASCULAR DISEASE In 2006 there were 80 million
More informationHigh-risk vulnerable plaques. Kostis Raisakis G.Gennimatas General Hospital of Athens
High-risk vulnerable plaques. Kostis Raisakis G.Gennimatas General Hospital of Athens Overview: 1 Definition-Pathology 2 3 Diagnostic Strategies Invasive Non Invasive Prognostic Value of Detection 4 Treatment
More informationCarotid Artery Stenting
Carotid Artery Stenting Woong Chol Kang M.D. Gil Medical Center, Gachon University of Medicine and Science, Incheon, Korea Carotid Stenosis and Stroke ~25% of stroke is due to carotid disease, the reminder
More informationPlaque Imaging: What It Can Tell Us. Kenneth Snyder, MD, PhD L Nelson Hopkins MD FACS Elad Levy MD MBA FAHA FACS Adnan Siddiqui MD PhD
Plaque Imaging: What It Can Tell Us Kenneth Snyder, MD, PhD L Nelson Hopkins MD FACS Elad Levy MD MBA FAHA FACS Adnan Siddiqui MD PhD Buffalo Disclosure Information FINANCIAL DISCLOSURE: Research and consultant
More informationDisclosures. State of the Art Management of Carotid Stenosis. NIH funding for clinical trials Consultant for Scientia Vascular and Medtronic
State of the Art Management of Carotid Stenosis Mark R. Harrigan, MD UAB Stroke Center Professor of Neurosurgery, Neurology, and Radiology University of Alabama, Birmingham Disclosures NIH funding for
More informationPathology of Coronary Artery Disease
Pathology of Coronary Artery Disease Seth J. Kligerman, MD Pathology of Coronary Artery Disease Seth Kligerman, MD Assistant Professor Medical Director of MRI University of Maryland Department of Radiology
More informationMorphological duplex ultrasound criteria how to assess and report echolucency, inhomogeneity and ulceration
Morphological duplex ultrasound criteria how to assess and report echolucency, inhomogeneity and ulceration Prof. Daniel Staub, Angiology, University Hospital Basel, Switzerland daniel.staub@usb.ch Disclosure
More informationInvasive Coronary Imaging Modalities for Vulnerable Plaque Detection
Invasive Coronary Imaging Modalities for Vulnerable Plaque Detection Gary S. Mintz, MD Cardiovascular Research Foundation New York, NY Greyscale IVUS studies have shown Plaque ruptures do not occur randomly
More informationContemporary Carotid Imaging and Approach to Treatment: Course Notes Thursday, June 22, 2017 David M. Pelz, MD, FRCPC
CNSF Meeting, Victoria, BC. June 2017 Contemporary Carotid Imaging and Approach to Treatment: Course Notes Thursday, June 22, 2017 David M. Pelz, MD, FRCPC A. Objectives 1. To understand the current imaging
More informationImaging Overview for Vulnerable Plaque: Data from IVUS Trial and An Introduction to VH-IVUS Imgaging
Imaging Overview for Vulnerable Plaque: Data from IVUS Trial and An Introduction to VH-IVUS Imgaging Gary S. Mintz,, MD Cardiovascular Research Foundation New York, NY Today, in reality, almost everything
More informationTreatment Considerations for Carotid Artery Stenosis. Danielle Zielinski, RN, MSN, ACNP Rush University Neurosurgery
Treatment Considerations for Carotid Artery Stenosis Danielle Zielinski, RN, MSN, ACNP Rush University Neurosurgery 4.29.2016 There is no actual or potential conflict of interest in regards to this presentation
More informationCarotid Artery Stenosis
Evidence-Based Approach to Carotid Artery Stenosis Seong-Wook Park, MD Division of Cardiology, Asan Medical Center University of Ulsan College of Medicine, Seoul, Korea Carotid Artery Stenosis Carotid
More informationPre-and Post Procedure Non-Invasive Evaluation of the Patient with Carotid Disease
Pre-and Post Procedure Non-Invasive Evaluation of the Patient with Carotid Disease Michael R. Jaff, D.O., F.A.C.P., F.A.C.C. Assistant Professor of Medicine Harvard Medical School Director, Vascular Medicine
More informationImportance of changes in thoracic and abdominal aortic stiffness following stent graft implantation
14/9/2018 Importance of changes in thoracic and abdominal aortic stiffness following stent graft implantation Christos D. Liapis, MD, FACS, FRCS, FEBVS Professor (Em) of Vascular Surgery National & Kapodistrian
More informationContemporary Management of Carotid Disease What We Know So Far
Contemporary Management of Carotid Disease What We Know So Far Ammar Safar, MD, FSCAI, FACC, FACP, RPVI Interventional Cardiology & Endovascular Medicine Disclosers NONE Epidemiology 80 % of stroke are
More informationVascular disease. Structural evaluation of vascular disease. Goo-Yeong Cho, MD, PhD Seoul National University Bundang Hospital
Vascular disease. Structural evaluation of vascular disease Goo-Yeong Cho, MD, PhD Seoul National University Bundang Hospital resistance vessels : arteries
More informationState of the Art. Advances in Cardiovascular Imaging. ESC Congres Stockholm September 1, 2010 Frank E. Rademakers, MD, PhD, FESC
State of the Art Advances in Cardiovascular Imaging ESC Congres Stockholm September 1, 2010 Frank E. Rademakers, MD, PhD, FESC Coronary Artery Disease Content Patho Physiology Imaging requirements Economical
More informationAdded Value of Invasive Coronary Imaging for Plaque Rupture and Erosion
Assessment of Coronary Plaque Rupture and Erosion Added Value of Invasive Coronary Imaging for Plaque Rupture and Erosion Yukio Ozaki, MD, PhD, FACC, FESC Cardiology Dept., Fujita Health Univ. Toyoake,
More informationOCT. molecular imaging J Jpn Coll Angiol, 2008, 48: molecular imaging MRI positron-emission tomography PET IMT
48 6 CT MRI PET OCT molecular imaging J Jpn Coll Angiol, 2008, 48: 456 461 atherosclerosis, imaging gold standard computed tomography CT magnetic resonance imaging MRI CT B intima media thickness IMT B
More informationChapter 43 Noninvasive Coronary Plaque Imaging
hapter 43 Noninvasive oronary Plaque Imaging NIRUDH KOHLI The goal of coronary imaging is to define the extent of luminal narrowing as well as composition of an atherosclerotic plaque to facilitate appropriate
More informationOptical Coherence Tomography (OCT): A New Imaging Tool During Carotid Artery Stenting
Chapter 6 Optical Coherence Tomography (OCT): A New Imaging Tool During Carotid Artery Stenting Shinichi Yoshimura, Masanori Kawasaki, Kiyofumi Yamada, Arihiro Hattori, Kazuhiko Nishigaki, Shinya Minatoguchi
More informationCoronary Artery Thermography
Coronary Artery Thermography The 10th Anniversary, Interventional Vascular Therapeutics Angioplasty Summit 2005 TCT Asia Pacific Christodoulos Stefanadis Professor of Cardiology Athens Medical School In
More informationCarotid Artery Stenting
Carotid Artery Stenting JESSICA MITCHELL, ACNP CENTRAL ILLINOIS RADIOLOGICAL ASSOCIATES External Carotid Artery (ECA) can easily be identified from Internal Carotid Artery (ICA) by noticing the branches.
More informationEmboli detection to evaluate risk of stroke
Emboli detection to evaluate risk of stroke Background: Improved methods are required to identify patients with asymptomatic carotid stenosis at high risk for stroke. Whether surgery is beneficial for
More informationAdvances in the treatment of posterior cerebral circulation symptomatic disease
Advances in the treatment of posterior cerebral circulation symptomatic disease Athanasios D. Giannoukas MD, MSc(Lond.), PhD(Lond.), FEBVS Professor of Vascular Surgery Faculty of Medicine, School of Health
More informationCarotid Artery Disease and What s Pertinent JOSEPH A PAULISIN DO
Carotid Artery Disease and What s Pertinent JOSEPH A PAULISIN DO Goal of treatment of carotid disease Identify those at risk of developing symptoms Prevent patients at risk from developing symptoms Prevent
More informationIVUS Virtual Histology. Listening through Walls D. Geoffrey Vince, PhD The Cleveland Clinic Foundation
IVUS Virtual Histology Listening through Walls D. Geoffrey Vince, PhD Disclosure VH is licenced to Volcano Therapeutics Grant funding from Pfizer, Inc. Grant funding from Boston-Scientific Most Myocardial
More informationCarotid Artery Stent: Is it ready for prime time?
2010 CATH LAB SYMPOSIUM Carotid Artery Stent: Is it ready for prime time? Luis F. Tami, MD, FACC, FSCAI Interventional Cardiology and Vascular Medicine Memorial Regional Hospital August 2010 CAE and CAS
More informationThe most important recommendations from the 2017 ESVS/ESC guideline on the management of carotid artery disease
The most important recommendations from the 2017 ESVS/ESC guideline on the management of carotid artery disease GJ de Borst Department of Vascular Surgery RECOMMENDATION GRADING CRITERIA What is new
More informationCAROTID STENTING A 2009 UPDATE. Hoang Duong, MD Director of Interventional Neuroradiology Memorial Regional Hospital
CAROTID STENTING A 2009 UPDATE Hoang Duong, MD Director of Interventional Neuroradiology Memorial Regional Hospital TREATMENT FOR CAROTID STENOSIS Best medical management Antiplatelet therapy Antihypertensive
More informationCLINICAL APPLICATIONS OF OPTICAL COHERENCE TOMOGRAPHY. Konstantina P. Bouki, FESC 2 nd Department of Cardiology General Hospital Of Nikea, Pireaus
CLINICAL APPLICATIONS OF OPTICAL COHERENCE TOMOGRAPHY Konstantina P. Bouki, FESC 2 nd Department of Cardiology General Hospital Of Nikea, Pireaus OPTICAL COHERENCE TOMOGRAPHY (OCT) IVUS and OCT IVUS OCT
More informationSpontaneous embolisation on TCD and carotid plaque features
Spontaneous embolisation on TCD and carotid plaque features J. David Spence Stroke Prevention & Atherosclerosis Research Centre Robarts Research Institute London, Canada dspence@robarts.ca www.imaging.robarts.ca/sparc
More informationΗ Πυρηνική Καρδιολογία Το 2017 ΟΜΑΔΑ ΕΡΓΑΣΙΑΣ ΑΠΕΙΚΟΝΙΣΤΙΚΩΝ ΤΕΧΝΙΚΩΝ
Η Πυρηνική Καρδιολογία Το 2017 ΟΜΑΔΑ ΕΡΓΑΣΙΑΣ ΑΠΕΙΚΟΝΙΣΤΙΚΩΝ ΤΕΧΝΙΚΩΝ huma human n Setting diagnosis of the early stages of chronic diseases (i.e cancer, neuropsychiatric, cardiovascular disorders), in
More informationThe 10 th International & 15 th National Congress on Quality Improvement in Clinical Laboratories
The 10 th International & 15 th National Congress on Quality Improvement in Clinical Laboratories Cardiac biomarkers in atherosclerosis Najma Asadi MD-APCP Ross and Colleagues in 1973: Response to Injury
More informationCarotid Artery Stenting (CAS) Pathophysiology. Technical Considerations. Plaque characteristics: relevant concepts. CAS and CEA
Carotid Artery Stenting (CAS) Carotid Artery Stenting for Stroke Risk Reduction Matthew A. Corriere MD, MS, RPVI Assistant Professor of Surgery Department of Vascular and Endovascular Surgery Rationale:
More informationGary S. Mintz,, MD. IVUS Observations in Acute (vs Chronic) Coronary Artery Disease: Structure vs Function
Gary S. Mintz,, MD IVUS Observations in Acute (vs Chronic) Coronary Artery Disease: Structure vs Function Important IVUS Observations: Remodeling Originally used (first by Glagov) ) to explain atherosclerosis
More informationVulnerable Plaque Pathophysiology, Detection, and Intervention. VP: A Local Problem or Systemic Disease. Erling Falk, Denmark
Vulnerable Plaque Pathophysiology, Detection, and Intervention VP: A Local Problem or Systemic Disease Erling Falk, Denmark Vulnerable Plaque Pathophysiology, Detection, and Intervention VP: A Local Problem
More informationIssam D. Moussa, MD. Professor of Medicine Mayo Clinic College of Medicine Chair, Division of Cardiovascular Diseases Mayo Clinic Jacksonville, FL
Carotid Technologies and Protection Issam D. Moussa, MD Professor of Medicine Mayo Clinic College of Medicine Chair, Division of Cardiovascular Diseases Mayo Clinic Jacksonville, FL Disclosure Statement
More informationWill Mesh-covered Stents Help Reduce the Risk of Stroke? Peter A. Schneider, MD Kaiser Foundation Hospital Honolulu, Hawaii
Will Mesh-covered Stents Help Reduce the Risk of Stroke? Peter A. Schneider, MD Kaiser Foundation Hospital Honolulu, Hawaii Disclosure Peter A. Schneider... I have the following potential conflicts of
More informationThe PROSPECT Trial. A Natural History Study of Atherosclerosis Using Multimodality Intracoronary Imaging to Prospectively Identify Vulnerable Plaque
The PROSPECT Trial Providing Regional Observations to Study Predictors of Events in the Coronary Tree A Natural History Study of Atherosclerosis Using Multimodality Intracoronary Imaging to Prospectively
More informationAssessment of Vulnerable Plaque by IVUS and VH-IVUS
Assessment of Vulnerable Plaque by IVUS and VH-IVUS Akiko Maehara, MD Director of Intravascular Imaging & Physiology Core Laboratories Associate Director of MRI/MDCT Core Laboratory Cardiovascular Research
More informationNoninvasive Coronary Imaging: Plaque Imaging by MDCT
Coronary Physiology & Imaging Summit 2007 Noninvasive Coronary Imaging: Plaque Imaging by MDCT Byoung Wook Choi Department of Radiology Yonsei University, Seoul, Korea Stary, H. C. et al. Circulation
More informationa physician-initiated study investigating the RoadSaver stent in carotid lesions Dr. Michel Bosiers
The study a physician-initiated study investigating the RoadSaver stent in carotid lesions Dr. Michel Bosiers Conflict of interest have the following potential conflicts of interest to report: Consulting
More informationCottrell Memorial Lecture. Has Reversing Atherosclerosis Become the New Gold Standard in the Treatment of Cardiovascular Disease?
Cottrell Memorial Lecture Has Reversing Atherosclerosis Become the New Gold Standard in the Treatment of Cardiovascular Disease? Stephen Nicholls MBBS PhD @SAHMRI_Heart Disclosures Research support: AstraZeneca,
More informationCardioLucca2014. Fare luce sulla scelta ottimale del trattamento nella rivascolarizzazione delle stenosi carotidee. Fabrizio Tomai
CardioLucca2014 Fare luce sulla scelta ottimale del trattamento nella rivascolarizzazione delle stenosi carotidee Fabrizio Tomai European Hospital e Aurelia Hospital Roma Treatment of Carotid Artery Disease
More information1st Department of Cardiology, University of Athens, Hippokration Hospital, Athens, Greece
Konstantinos Toutouzas, Maria Riga, Antonios Karanasos, Eleftherios Tsiamis, Andreas Synetos, Maria Drakopoulou, Chrysoula Patsa, Georgia Triantafyllou, Aris Androulakis, Christodoulos Stefanadis 1st Department
More informationAssessment of plaque morphology by OCT in patients with ACS
Assessment of plaque morphology by OCT in patients with ACS Takashi Akasaka, M.D. Department of Cardiovascular Medicine Wakayama, Japan Unstable plaque Intima Lipid core Plaque rupture and coronary events
More informationAlgorithmic selection of emboli protection device during the procedure of carotid artery stunting
Algorithmic selection of emboli protection device during the procedure of carotid artery stunting Yasuhiro Kawabata, Tetsuya Tsukahara, Shunichi Fukuda, Tomokazu Aoki, Satoru Kawarazaki Department of Neurosurgery,
More informationEVAR follow up: answers to uncertainties Moderators F. Moll, Y. Alimi, M. Bjorck. Inflammatory response after EVAR: causes and clinical implication
39 th Annual Meeting, Boston, Sept. 2012 EVAR follow up: answers to uncertainties Moderators F. Moll, Y. Alimi, M. Bjorck Inflammatory response after EVAR: causes and clinical implication Christos D. Liapis,
More informationInternal carotid artery near-total occlusions: Is it justified to operate on them?
Internal carotid artery near-total occlusions: Is it justified to operate on them? Christos D. Liapis Professor (Em) of Vascular Surgery Athens University Medical School Director Vascular & Endovascular
More informationNon-invasive Imaging of Carotid Artery Atherosclerosis
Non-invasive Imaging of Carotid Artery Atherosclerosis 최연현 성균관의대삼성서울병원영상의학과 Noninvasive Techniques US with Doppler CT MRI Ultrasonography Techniques of Carotid US US Anatomy (ICA vs ECA) Gray scale and
More informationThe PROSPECT Trial. A Natural History Study of Atherosclerosis Using Multimodality Intracoronary Imaging to Prospectively Identify Vulnerable Plaque
The PROSPECT Trial Providing Regional Observations to Study Predictors of Events in the Coronary Tree A Natural History Study of Atherosclerosis Using Multimodality Intracoronary Imaging to Prospectively
More informationCarotid Stenting and Surgery in 2016 in Russia
Carotid Stenting and Surgery in 2016 in Russia Novosibirsk research institute of circulation pathology named by Meshalkin, Novosibirsk, Russia Starodubtsev V., Karpenko A., Ignatenko P. Annually in Russia
More informationCulprit Lesion Remodeling and Long-term (> 5years) Prognosis in Patients with Acute Coronary Syndrome
Culprit Lesion Remodeling and Long-term (> 5years) Prognosis in Patients with Acute Coronary Syndrome Hiroyuki Okura*, MD; Nobuya Matsushita**,MD Kenji Shimeno**, MD; Hiroyuki Yamaghishi**, MD Iku Toda**,
More informationCarotid Artery Disease How the Data Will Influence Management The Symptomatic vs. the Asymptomatic Patient
Carotid Artery Disease How the 2014-2015 Data Will Influence Management The Symptomatic vs. the Asymptomatic Patient Christopher J. White, MD, MSCAI, FACC, FAHA, FESC Professor and Chair of Medicine Ochsner
More informationThe CARENET all-comer trial using the CGuard micronet covered carotid embolic prevention stent
The CARENET all-comer trial using the CGuard micronet covered carotid embolic prevention stent 6 month data Piotr Musialek, MD DPhil FESC Jagiellonian University Dept. of Cardiac & Vascular Diseases John
More informationTitle for Paragraph Format Slide
Title for Paragraph Format Slide Presentation Title: Month Date, Year Atherosclerosis A Spectrum of Disease: February 12, 2015 Richard Cameron Padgett, MD Executive Medical Director, OHVI Pt RB Age 38
More informationESC Congress 2011 SIMULTANEOUS HYBRID REVASCULARIZATION OF CAROTID AND CORONARY DISEASE INITIAL RESULTS OF A NEW THERAPEUTIC APPROACH
ESC Congress 2011 SIMULTANEOUS HYBRID REVASCULARIZATION OF CAROTID AND CORONARY DISEASE IN PATIENTS WITH ACUTE CORONARY SYNDROME: INITIAL RESULTS OF A NEW THERAPEUTIC APPROACH AUTHORS: Marta Ponte 1, RICARDO
More informationCarotid artery percutaneous treatment: back to the future Alberto Cremonesi MD, FESC
Carotid artery percutaneous treatment: back to the future Alberto Cremonesi MD, FESC GVM Care & Research - Cardiovascular Department (Cotignola Italy) Hypothesis: Does CAS present similar outcomes than
More informationCardiovascular Research Foundation and Columbia University Medical Center, New York.
Virtual Histology Intravascular Ultrasound Analysis of Non-culprit Attenuated Plaques Detected by Grayscale Intravascular Ultrasound in Patients with Acute Coronary Syndromes Xiaofan Wu, Akiko Maehara,
More informationWilliam A. Gray MD System Chief of Cardiovascular Services, Main Line Health President, Lankenau Heart Institute Wynnewood, PA USA
William A. Gray MD System Chief of Cardiovascular Services, President, Wynnewood, PA USA What are the possible causes of stroke in CAS? Operator error Technique (balloon sizing, wire misadventure, EPD
More informationMR Imaging of Atherosclerotic Plaques
MR Imaging of Atherosclerotic Plaques Yeon Hyeon Choe, MD Department of Radiology, Samsung Medical Center, Sungkyunkwan University, Seoul MRI for Carotid Atheroma Excellent tissue contrast (fat, fibrous
More informationPlaque protrusion during carotid artery stenting: risk factors determined by MR plaque imaging
Plaque protrusion during carotid artery stenting: risk factors determined by MR plaque imaging Katsutoshi Takayama, M.D., Ph.D. Department of Radiology and Interventional neuroradiology, Ishinkai Yao General
More informationCarotid Intravascular Imaging Technique and Indication
Nurse and Technician Forum Carotid Intravascular Imaging Technique and Indication Gianmarco de Donato Assistant Professor Vascular and Endovascular Surgery University of Siena - Italy Disclosure Speaker
More informationStroke prevention in asymptomatic carotid stenosis. ΛΙΛΛΗΣ ΛΕΩΝΙΔΑΣ Καρδιολόγος Επιστημονικός Συνεργάτης Α Καρδιολογικής Κλινικής ΑΠΘ ΠΓΝΘ ΑΧΕΠΑ
Stroke prevention in asymptomatic carotid stenosis ΛΙΛΛΗΣ ΛΕΩΝΙΔΑΣ Καρδιολόγος Επιστημονικός Συνεργάτης Α Καρδιολογικής Κλινικής ΑΠΘ ΠΓΝΘ ΑΧΕΠΑ Σεμινάρια Ομάδων Εργασίας Ελληνικής Καρδιολογικής Εταιρείας
More informationCan We Identify Vulnerable Patients & Vulnerable Plaque?
Can We Identify Vulnerable Patients & Vulnerable Plaque? We Know Enough to Treat High-Risk Lesions? Takashi Akasaka, MD, PhD Department of Cardiovascular Medicine, Japan Disclosure Statement of Financial
More informationNUCLEAR CARDIOLOGY AND ADVANCED VASCULAR IMAGING. Joel Kahn, MD, FACC
NUCLEAR CARDIOLOGY AND ADVANCED VASCULAR IMAGING Joel Kahn, MD, FACC Short History Nuclear Cardiology Hermann blumgart-1927-injected radon to measure circulation time Hal Anger-1952-gamma camera-beginning
More informationI have the following potential conflicts of interest to report. honorarium: 1. St Jude Medical 2. Biotronik 3. Boston Scientific
Stenting carotideo nel paziente sintomatico alla luce dei nuovi trials Savona, 11 Aprile 2015 Gioel GabrioSecco, MD, PhD Emodinamica e CardiologiaInterventistica Ospedale SantiAntonio e Biagio e Cesare
More informationLeft main coronary artery (LMCA): The proximal segment
Anatomy and Pathology of Left main coronary artery G Nakazawa Tokai Univ. Kanagawa, Japan 1 Anatomy Difinition Left main coronary artery (LMCA): The proximal segment RCA AV LAD LM LCX of the left coronary
More informationMolecular Imaging of Coronary Plaques
Molecular Imaging of Coronary Plaques Daniel S. Berman, MD Director, Cardiac Imaging Cedars-Sinai Heart Institute CSMC 20113 Professor of Medicine David Geffen School of Medicine at UCLA Zahi A. Fayad,
More informationA Novel Low Pressure Self Expanding Nitinol Coronary Stent (vprotect): Device Design and FIH Experience
A Novel Low Pressure Self Expanding Nitinol Coronary Stent (vprotect): Device Design and FIH Experience Juan F. Granada, MD Medical Director, Skirball Center for Cardiovascular Research The Cardiovascular
More informationAsymptomatic Carotid Stenosis To Do or Not To Do
Asymptomatic Carotid Stenosis To Do or Not To Do October 22, 2016 Neurosciences: Updates and Controversies Andrew C. MacDougall, MD Advocate Medical Group Advocate Lutheran General Hospital Principle
More informationLecture Outline: 1/5/14
John P. Karis, MD Lecture Outline: Provide a clinical overview of stroke: Risk Prevention Diagnosis Intervention Illustrate how MRI is used in the diagnosis and management of stroke. Illustrate how competing
More informationCarlo Setacci Chief Department of Surgery Vascular and Endovascular Unit University of Siena
Which carotid procedures are required to grade the stroke risk? Carlo Setacci Chief Department of Surgery Vascular and Endovascular Unit University of Siena Faculty disclosure Carlo Setacci I have no financial
More informationCAROTID ANGIOPLASTY AND STENTING UNDER PROTECTION IS BECOMING THE GOLD STANDARD TREATMENT IN HIGH AND LOW RISK PATIENTS
CAROTID ANGIOPLASTY AND STENTING UNDER PROTECTION IS BECOMING THE GOLD STANDARD TREATMENT IN HIGH AND LOW RISK PATIENTS M. HENRY* MD, I. HENRY MD A. POLYDOROU MD, A.D. POLYDOROU MD M. HUGEL RN NANCY FRANCE
More informationTHE COMPLEX RELATION BETWEEN VULNERABILITY AND ISCHEMIA a paradigm shift
THE COMPLEX RELATION BETWEEN VULNERABILITY AND ISCHEMIA a paradigm shift Angioplasty Summit TCT ASIA Seoul, Korea, april 23rd, 2008 Nico H. J. Pijls, MD, PhD Catharina Hospital, Eindhoven, The Netherlands
More informationIndex. interventional.theclinics.com. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A ACAS (Asymptomatic Carotid Atherosclerosis Study), 65 66 ACST (Asymptomatic Carotid Surgery Trial), 6 7, 65, 75 Age factors, in carotid
More informationcollaterals offset ischemia
Imaging of Intracranial Stenosis objectives & next steps collaterals offset ischemia systematic evaluation of collaterals hemodynamic impact, not % stenosis develop fractional flow measures collateral
More informationCoronary Artery Imaging. Suvipaporn Siripornpitak, MD Inter-hospital Conference : Rajavithi Hospital
Coronary Artery Imaging Suvipaporn Siripornpitak, MD Inter-hospital Conference : Rajavithi Hospital Larger array : cover scan area Detector size : spatial resolution Rotation speed : scan time Retrospective
More informationRecanalization of Chronic Carotid Artery Occlusion Objective Improvement Of Cerebral Perfusion
Recanalization of Chronic Carotid Artery Occlusion Objective Improvement Of Cerebral Perfusion Paul Hsien-Li Kao, MD Assistant Professor National Taiwan University Medical School and Hospital ICA stenting
More informationESC Heart & Brain Workshop
ESC Heart & Brain Workshop The role of vascular surgeon in stroke prevention Barbara Rantner, MD, PhD, Department of Vascular Surgery, Medical University Innsbruck, Innsbruck, Austria Supported by Bayer,
More informationSubclinical atherosclerosis in CVD: Risk stratification & management Raul Santos, MD
Subclinical atherosclerosis in CVD: Risk stratification & management Raul Santos, MD Sao Paulo Medical School Sao Paolo, Brazil Subclinical atherosclerosis in CVD risk: Stratification & management Prof.
More informationRandomised Trials of Carotid Interventions Will the Changing Technology of Membrane Mesh Stents Shape The Future?
Randomised Trials of Carotid Interventions Will the Changing Technology of Membrane Mesh Stents Shape The Future? Dr Sumaira Macdonald MBChB (Comm.), FRCP, FRCR, PhD, EBIR Vascular Interventional Radiologist
More informationUniversity of Groningen. Optimizing care for patients with symptomatic carotid disease Kolkert, Joe
University of Groningen Optimizing care for patients with symptomatic carotid disease Kolkert, Joe IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite
More informationPost-Procedural Myocardial Injury or Infarction
Post-Procedural Myocardial Injury or Infarction Hugo A Katus MD & Evangelos Giannitsis MD Abteilung Innere Medizin III Kardiologie, Angiologie, Pulmologie Universitätsklinikum Heidelberg Conflict of Interest:
More informationSide effects of TEVAR and EVAR on the heart: Myth or reality?
Side effects of TEVAR and EVAR on the heart: Myth or reality? Christos D. Liapis, MD, FACS, FRCS, FEBVS Professor (Em) of Vascular Surgery National & Kapodistrian University of Athens Director Vascular
More informationQuinn Capers, IV, MD
Heart Attacks Mended Hearts Presentation, January, 2017 Quinn Capers, IV, MD Associate Professor of Medicine (Cardiovascular Medicine) Director, Transradial Coronary Interventions Division of Cardiovascular
More informationUpdated Society for Vascular Surgery guidelines for management of extracranial carotid disease: Executive summary
SOCIETY FOR VASCULAR SURGERY DOCUMENT Updated Society for Vascular Surgery guidelines for management of extracranial carotid disease: Executive summary John J. Ricotta, MD, a Ali AbuRahma, MD, FACS, b
More informationCarotid Ddisease, Carotid IMT and Risk of Stroke
Carotid Ddisease, Carotid IMT and Risk of Stroke TATJANA RUNDEK, MD PhD Professor of Neurology, Epidemiology and Public Health Director, Clinical translational Division Department of Neurology, Miller
More informationIntervention: How and to which extent is technology helping us?
Cardiological Society of India Congress 12th February 2016 Chennai, India Intervention: How and to which extent is technology helping us? SIMONE BISCAGLIA MD CARDIOVASCULAR INSTITUTE, FERRARA, ITALY Introduction
More informationPrise en charge du polyvasculaire
Prise en charge du polyvasculaire Dépistage et prise en charge des sténoses carotidiennes Serge Kownator Centre cardiologique et Vasculaire - Thionville Disclosure Statement of Financial Interest I currently
More informationI want Medical Therapy for my ASYMPTOMATIC patients with Carotid Disease
I want Medical Therapy for my ASYMPTOMATIC patients with Carotid Disease Alonso Collar, M.D. F.A.C.S. Chief of Surgery Chair Cardiovascular Surgery Sparrow Hospital Lansing, MI I want Medical Therapy for
More informationOCT; Comparative Imaging Results with IVUS, VH and Angioscopy
OCT; Comparative Imaging Results with IVUS, VH and Angioscopy Takashi Akasaka, M.D. Department of Cardiovascular Medicine Wakayama, Japan Comparison among coronary imaging techniques OCT IVUS MRI CAG Angioscopy
More informationCHAPTER (2) THE VULNERABLE PLAQUE
CHAPTER (2) THE VULNERABLE PLAQUE UNSTABLE OR HIGH RISK ATHEROSCLEROTIC PLAQUE - Definition and Composition - Plaque Destabilization and Disruption - Fate of Disrupted Plaque - Clinical Presentation -
More informationCardiac CT Angiography
Cardiac CT Angiography Dr James Chafey, Radiologist Why do we need a better test for C.A.D? 1. CAD is the leading cause of death in the US CAD 31% Cancer 23% Stroke 7% 2. The prevalence of atherosclerosis
More informationCarotid Endarterectomy for Symptomatic Complete Occlusion of the Internal Carotid Artery
2011 65 4 239 245 Carotid Endarterectomy for Symptomatic Complete Occlusion of the Internal Carotid Artery a* a b a a a b 240 65 4 2011 241 9 1 60 10 2 62 17 3 67 2 4 64 7 5 69 5 6 71 1 7 55 13 8 73 1
More informationSurgical Procedures for. Symptomatic Post-CAS Carotid. Restenosis: Experiences and. Mid-Term Outcomes. Lefeng Qu M.D., Ph.D. Professor of Surgery
Surgical Procedures for Symptomatic Post-CAS Carotid Restenosis: Experiences and Mid-Term Outcomes Lefeng Qu M.D., Ph.D. Professor of Surgery Department of Vascular and Endovascular Surgery, Changzheng
More informationIVUS Analysis. Myeong-Ki. Hong, MD, PhD. Cardiac Center, Asan Medical Center University of Ulsan College of Medicine, Seoul, Korea
IVUS Analysis Myeong-Ki Hong, MD, PhD Cardiac Center, Asan Medical Center University of Ulsan College of Medicine, Seoul, Korea Intimal disease (plaque) is dense and will appear white Media is made of
More information2yrs 2-6yrs >6yrs BMS 0% 22% 42% DES 29% 41% Nakazawa et al. J Am Coll Cardiol 2011;57:
Pathology of In-stent Neoatherosclerosis in BMS and DES 197 BMS, 103 SES, and 106 PES with implant duration >30 days The incidence of neoatherosclerosis was significantly greater in DES (31%) than BMS
More information